|
**Overview**: Allergy Tree Panel**Introduction**: The Allergy Tree Panel is a diagnostic tool designed to screen for tree pollen allergies using serum samples. In India, tree pollen sensitization contributes to seasonal allergic rhinitis and asthma (prevalence 10-25 percent in rhinitis cohorts), with common species including Eucalyptus, Oak, Elm, Birch, and Pine in urban green areas and northern/hilly regions. Symptoms include sneezing, nasal congestion, eye itching, and wheezing during spring pollen seasons. High morbidity from underdiagnosis in pollen-exposed populations, limited testing in non-metro areas, and overlap with viral infections. Per immunology practices aligned with ICMR guidelines, the test employs immunoassay for detailed parameter analysis over 1-2 days with high sensitivity/specificity, valuable for identifying tree pollen triggers in seasonal cases. This diagnostic falls under allergy screening and targets individuals with suspected tree pollen allergies, addressing accurate detection to guide avoidance, pharmacotherapy, or immunotherapy. With morbidity elevated due to underdiagnosis in urban and peri-urban settings, the test supports public health efforts by enabling precise identification, facilitating management, and reducing seasonal exacerbations. Its serum-based approach ensures reliable detection.**Other Names**: Tree Pnl.**FDA Status**: FDA approved, CLIA certified for immunology, compliant with 2025 standards.**Historical Milestone**: Expanded with specific IgE testing; in India, relevance with tree pollen exposure in cities and hilly areas.**Purpose**: The test screens for 6 parameters including Eucalyptus IgE to guide tree pollen allergy assessment, identify triggers, inform treatment strategies.**Test Parameters**: 1. Eucalyptus IgE, 2. Oak IgE, 3. Elm IgE, 4. Birch IgE, 5. Pine IgE, 6. Total IgE.**Pretest Condition**: No fasting required; patients should report seasonal sneezing, nasal congestion, eye itching, or asthma worsening.**Specimen**: 3 mL serum in 1 SST, transported within specified times to maintain sample viability.**Sample Stability at Room Temperature**: 8 hours with proper handling to preserve analyte integrity, ensuring reliable test performance.**Sample Stability at Refrigeration**: 7 days at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.**Sample Stability at Frozen**: 6 months at -20 degrees Celsius, allowing long-term storage for retesting, though freezing may affect some analytes.**Medical History**: Patients should provide details on symptom seasonality, outdoor tree exposure, pollen seasons, or family atopy.**Consent**: Written informed consent is required, detailing the test's purpose, potential risks of untreated tree pollen allergies including chronic rhinitis or asthma, benefits of early detection, and minimal discomfort from venipuncture.**Procedural Considerations**: The test involves sample processing using immunoassay by trained personnel to ensure sterile technique, avoid hemolysis, and interpret results within 1-2 days using provided controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols, and store kits according to manufacturer specifications to ensure reliability.**Factors Affecting Result Accuracy**: Delays beyond stability periods, improper storage conditions, hemolysis, or concurrent infections can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.**Clinical Significance**: Abnormal results indicate possible tree pollen triggers, necessitating further investigation like specialist consultation or additional testing. Normal results may require follow-up if symptoms persist.**Specialist Consultation**: Allergists or pulmonologists should be consulted for case management, treatment planning, and coordination with health programs.**Additional Supporting Tests**: Pollen count correlation or skin prick test for confirmation.**Test Limitations**: The test may produce false negatives in off-season or false positives in sensitization without clinical disease, requiring a comprehensive diagnostic approach that includes clinical correlation.**References**: Indian Journal of Allergy Asthma Immunology 2024, Pollen Allergen Studies India 2023. |
